The Nutshell

» funding, genetics & genomics and cancer

Daily News Roundup

Most Recent

image: 23andMe Markets Genome Kits to Researchers

23andMe Markets Genome Kits to Researchers

By | July 14, 2016

Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.

0 Comments

image: Open Letter Leads to Peer Review Changes

Open Letter Leads to Peer Review Changes

By | July 14, 2016

The Canadian Institutes of Health Research will reverse some of the recent changes to its grant-reviewing processes after protests from researchers.

0 Comments

image: Considering Gene Editing

Considering Gene Editing

By | July 12, 2016

An international committee continues its investigation into the ethical and social considerations of precision DNA editing technology with a public meeting held this morning in Washington, DC.

0 Comments

Juno Therapeutics asks the US Food and Drug Administration for permission to restart the CAR-T experiments without chemotherapy.

0 Comments

Nearly 1,200 scientists are asking the Canadian Institutes of Health Research to undo recent changes to its grant-review process.

0 Comments

image: CRISPR Combats Herpes

CRISPR Combats Herpes

By | July 5, 2016

Scientists use the gene editing technology to target active and latent virus in mammalian cell cultures.

0 Comments

Human cancer cells constrained to capillary-like microtubes divide unevenly, scientists show.

0 Comments

Ancient DNA research suggests that there were two independent agricultural revolutions more than 10,000 years ago.

1 Comment

image: Treating Cancer with CRISPR?

Treating Cancer with CRISPR?

By | June 17, 2016

A federal panel will review the first proposal for the use of the technology to edit human genes for medical purposes.

0 Comments

image: TS Picks: June 6, 2016

TS Picks: June 6, 2016

By | June 6, 2016

American Society of Clinical Oncology meeting edition 

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech